Search

everythinglearnresearchcommunity

for

Search:↓

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Dutasteride and finasteride affect different cell types differently.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Androgens slow hair growth by altering Wnt signaling in balding cells.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Human skin cells contain Protease Nexin-1, and male hormones can decrease its levels, potentially affecting hair growth.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Hsc70 protein may influence hair growth by responding to androgens.

DHT reduces a cell's ability to promote hair growth, while 3D culture without DHT improves it.

TGF-β1 from dermal papilla cells suppresses hair growth, and targeting it may help treat androgenetic alopecia.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Excess maternal androgens can cause heart problems in offspring.

Wnt3a activates certain genes in hair follicle cells, including a newly discovered one, EP2, which may affect hair growth.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Women with hair loss have more androgen receptors in certain hair follicles.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

Steroids, particularly estrogens and 5α-reductase inhibitors, affect blood vessel-related hair growth processes in hair follicle cells.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.